McGlone Suttner Wealth Management Inc. Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

McGlone Suttner Wealth Management Inc. acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 578 shares of the company’s stock, valued at approximately $235,000.

A number of other hedge funds also recently made changes to their positions in HCA. CreativeOne Wealth LLC acquired a new stake in HCA Healthcare during the 1st quarter worth approximately $231,000. New Mexico Educational Retirement Board lifted its holdings in HCA Healthcare by 29.9% during the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after purchasing an additional 3,200 shares during the last quarter. Kingswood Wealth Advisors LLC acquired a new stake in HCA Healthcare during the 1st quarter worth approximately $566,000. Bessemer Group Inc. lifted its holdings in HCA Healthcare by 51.2% during the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after purchasing an additional 2,584 shares during the last quarter. Finally, Empowered Funds LLC increased its stake in HCA Healthcare by 54.3% during the 1st quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock worth $4,639,000 after acquiring an additional 4,893 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,202 shares of company stock valued at $6,407,273. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 1.9 %

Shares of HCA opened at $394.54 on Monday. The company has a market capitalization of $103.34 billion, a PE ratio of 19.67, a PEG ratio of 1.44 and a beta of 1.67. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock’s 50-day moving average price is $387.15 and its two-hundred day moving average price is $347.49. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $409.42.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the previous year, the business earned $4.29 EPS. The firm’s revenue was up 10.3% compared to the same quarter last year. On average, analysts anticipate that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on HCA. UBS Group raised their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Deutsche Bank Aktiengesellschaft raised their price objective on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research note on Friday, June 28th. Wells Fargo & Company lifted their price target on HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 30th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Finally, Morgan Stanley began coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $365.65.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.